{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T16:04:42Z","timestamp":1700237082835},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T00:00:00Z","timestamp":1412899200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-230x-14-177","type":"journal-article","created":{"date-parts":[[2014,10,10]],"date-time":"2014-10-10T11:00:55Z","timestamp":1412938855000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Symptom profile in partial responders to a proton pump inhibitor compared with treatment-na\u00efve patients with gastroesophageal reflux disease: a post hoc analysis of two study populations"],"prefix":"10.1186","volume":"14","author":[{"given":"Nimish","family":"Vakil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Niklasson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Denison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,10]]},"reference":[{"issue":"6","key":"1200_CR1","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/j.1365-2036.2010.04406.x","volume":"32","author":"H El-Serag","year":"2010","unstructured":"El-Serag H, Becher A, Jones R: Systematic review: persistent reflux symptoms on proton pump inhibitor therapy in primary care and community studies. Aliment Pharmacol Ther. 2010, 32 (6): 720-737. 10.1111\/j.1365-2036.2010.04406.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"1200_CR2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.2165\/11595480-000000000-00000","volume":"31","author":"S Toghanian","year":"2011","unstructured":"Toghanian S, Johnson DA, Stalhammar NO, Zerbib F: Burden of gastro-oesophageal reflux disease in patients with persistent and intense symptoms despite proton pump inhibitor therapy: a post hoc analysis of the 2007 national health and wellness survey. Clin Drug Investig. 2011, 31 (10): 703-715. 10.2165\/11595480-000000000-00000.","journal-title":"Clin Drug Investig"},{"issue":"2","key":"1200_CR3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1365-2036.2005.02531.x","volume":"22","author":"R Fass","year":"2005","unstructured":"Fass R, Shapiro M, Dekel R, Sewell J: Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease \u2013 where next?. Aliment Pharmacol Ther. 2005, 22 (2): 79-94. 10.1111\/j.1365-2036.2005.02531.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1200_CR4","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/j.1365-2036.2010.04358.x","volume":"32","author":"GE Boeckxstaens","year":"2010","unstructured":"Boeckxstaens GE, Smout A: Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastroesophageal reflux disease. Aliment Pharmacol Ther. 2010, 32 (3): 334-343. 10.1111\/j.1365-2036.2010.04358.x.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"1200_CR5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1159\/000121354","volume":"26","author":"H Neumann","year":"2008","unstructured":"Neumann H, Monkemuller K, Kandulski A, Malfertheiner P: Dyspepsia and IBS symptoms in patients with NERD, ERD and Barrett\u2019s esophagus. Dig Dis. 2008, 26 (3): 243-247. 10.1159\/000121354.","journal-title":"Dig Dis"},{"issue":"10","key":"1200_CR6","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cgh.2011.05.015","volume":"9","author":"LB Gerson","year":"2011","unstructured":"Gerson LB, Kahrilas PJ, Fass R: Insights into gastroesophageal reflux disease-associated dyspeptic symptoms. Clin Gastroenterol Hepatol. 2011, 9 (10): 824-833. 10.1016\/j.cgh.2011.05.015.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"8","key":"1200_CR7","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N, Veldhuyzen van Zanten S, Kahrilas P, Dent J, Jones R: The Montreal definition and classification of gastro-esophageal reflux disease (GERD) \u2013 a global evidence-based consensus. Am J Gastroenterol. 2006, 101 (8): 1900-1920. 10.1111\/j.1572-0241.2006.00630.x.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1200_CR8","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/ajg.2013.89","volume":"108","author":"N Vakil","year":"2013","unstructured":"Vakil N, Halling K, Ohlsson L, Wernersson B: Symptom overlap between postprandial distress and epigastric pain syndromes of the Rome III dyspepsia classification. Am J Gastroenterol. 2013, 108 (5): 767-774. 10.1038\/ajg.2013.89.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"1200_CR9","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrgastro.2012.253","volume":"10","author":"EM Quigley","year":"2013","unstructured":"Quigley EM, Lacy BE: Overlap of functional dyspepsia and GERD\u2013diagnostic and treatment implications. Nat Rev Gastroenterol Hepatol. 2013, 10 (3): 175-186. 10.1038\/nrgastro.2012.253.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"35","key":"1200_CR10","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.3748\/wjg.v19.i35.5787","volume":"19","author":"N de Bortoli","year":"2013","unstructured":"de Bortoli N, Martinucci I, Bellini M, Savarino E, Savarino V, Blandizzi C, Marchi S: Overlap of functional heartburn and gastroesophageal reflux disease with irritable bowel syndrome. World J Gastroenterol. 2013, 19 (35): 5787-5797. 10.3748\/wjg.v19.i35.5787.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"1200_CR11","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1136\/gut.2008.175810","volume":"58","author":"E Savarino","year":"2009","unstructured":"Savarino E, Pohl D, Zentilin P, Dulbecco P, Sammito G, Sconfienza L, Vigneri S, Camerini G, Tutuian R, Savarino V: Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease. Gut. 2009, 58 (9): 1185-1191. 10.1136\/gut.2008.175810.","journal-title":"Gut"},{"key":"1200_CR12","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1038\/ctg.2012.1","volume":"3","author":"N Vakil","year":"2012","unstructured":"Vakil N, Bj\u00f6rck K, Denison H, Halling K, Karlsson M, Paty J, Silberg D, Ryd\u00e9n A: Validation of the Reflux Symptom Questionnaire electronic Diary in partial responders to proton pump inhibitor therapy. Clin Trans Gastroenterol. 2012, 3: e7-","journal-title":"Clin Trans Gastroenterol"},{"issue":"6","key":"1200_CR13","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1136\/gut.2009.200063","volume":"59","author":"J Dent","year":"2010","unstructured":"Dent J, Vakil N, Jones R, Bytzer P, Schoning U, Halling K, Junghard O, Lind T: Accuracy of the diagnosis of GORD by questionnaire, physicians and a trial of proton pump inhibitor treatment: the Diamond Study. Gut. 2010, 59 (6): 714-721. 10.1136\/gut.2009.200063.","journal-title":"Gut"},{"issue":"11","key":"1200_CR14","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.3109\/00365529509101605","volume":"30","author":"E Dimen\u00e4s","year":"1995","unstructured":"Dimen\u00e4s E, Glise H, Hallerb\u00e4ck B, Hernqvist H, Svedlund J, Wiklund I: Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol. 1995, 30 (11): 1046-1052. 10.3109\/00365529509101605.","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"1200_CR15","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1111\/j.1572-0241.2001.03932.x","volume":"96","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Fullerton S, Junghard O, Wiklund I: Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments. Am J Gastroenterol. 2001, 96 (7): 1998-2004. 10.1111\/j.1572-0241.2001.03932.x.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1200_CR16","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0895-4356(94)90036-1","volume":"47","author":"EF Juniper","year":"1994","unstructured":"Juniper EF, Guyatt GH, Willan A, Griffith LE: Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol. 1994, 47 (1): 81-87. 10.1016\/0895-4356(94)90036-1.","journal-title":"J Clin Epidemiol"},{"issue":"7132","key":"1200_CR17","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1136\/bmj.316.7132.690","volume":"316","author":"GH Guyatt","year":"1998","unstructured":"Guyatt GH, Juniper EF, Walter SD, Griffith LE, Goldstein RS: Interpreting treatment effects in randomised trials. BMJ. 1998, 316 (7132): 690-693. 10.1136\/bmj.316.7132.690.","journal-title":"BMJ"},{"issue":"2","key":"1200_CR18","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1136\/gut.2007.133470","volume":"57","author":"F Zerbib","year":"2008","unstructured":"Zerbib F, Duriez A, Roman S, Capdepont M, Mion F: Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors. Gut. 2008, 57 (2): 156-160. 10.1136\/gut.2007.133470.","journal-title":"Gut"},{"issue":"4","key":"1200_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.5056\/jnm.2011.17.4.387","volume":"17","author":"R Dickman","year":"2011","unstructured":"Dickman R, Boaz M, Aizic S, Beniashvili Z, Fass R, Niv Y: Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded. J Neurogastroenterol Motil. 2011, 17 (4): 387-394. 10.5056\/jnm.2011.17.4.387.","journal-title":"J Neurogastroenterol Motil"},{"issue":"4","key":"1200_CR20","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1136\/gutjnl-2011-300798","volume":"61","author":"F Zerbib","year":"2012","unstructured":"Zerbib F, Belhocine K, Simon M, Capdepont M, Mion F, Bruley des Varannes S, Galmiche JP: Clinical, but not oesophageal pH-impedance, profiles predict response to proton pump inhibitors in gastro-oesophageal reflux disease. Gut. 2012, 61 (4): 501-506. 10.1136\/gutjnl-2011-300798.","journal-title":"Gut"},{"issue":"45","key":"1200_CR21","doi-asserted-by":"publisher","first-page":"6009","DOI":"10.3748\/wjg.13.6009","volume":"13","author":"J Du","year":"2007","unstructured":"Du J, Liu J, Zhang H, Yu CH, Li YM: Risk factors for gastroesophageal reflux disease, reflux esophagitis and non-erosive reflux disease among Chinese patients undergoing upper gastrointestinal endoscopic examination. World J Gastroenterol. 2007, 13 (45): 6009-6015. 10.3748\/wjg.13.6009.","journal-title":"World J Gastroenterol"},{"key":"1200_CR22","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1136\/gut.2007.145581","volume":"58","author":"R Fass","year":"2009","unstructured":"Fass R, Sifrim D: Management of heartburn not responding to proton pump inhibitors. Gut. 2009, 58: 295-309. 10.1136\/gut.2007.145581.","journal-title":"Gut"},{"issue":"9","key":"1200_CR23","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1136\/gutjnl-2011-301897","volume":"61","author":"D Sifrim","year":"2012","unstructured":"Sifrim D, Zerbib F: Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors. Gut. 2012, 61 (9): 1340-1354. 10.1136\/gutjnl-2011-301897.","journal-title":"Gut"},{"issue":"8","key":"1200_CR24","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/ajg.2011.121","volume":"106","author":"NB Vakil","year":"2011","unstructured":"Vakil NB, Huff FJ, Bian A, Jones DS, Stamler D: Arbaclofen placarbil in GERD: a randomized, double-blind, placebo-controlled study. Am J Gastroenterol. 2011, 106 (8): 1427-1438. 10.1038\/ajg.2011.121.","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"1200_CR25","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1136\/gutjnl-2012-302737","volume":"62","author":"NJ Shaheen","year":"2013","unstructured":"Shaheen NJ, Denison H, Bjorck K, Karlsson M, Silberg DG: Efficacy and safety of lesogaberan in gastro-oesophageal reflux disease: a randomised controlled trial. Gut. 2013, 62 (9): 1248-1255. 10.1136\/gutjnl-2012-302737.","journal-title":"Gut"},{"issue":"2","key":"1200_CR26","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/apt.12363","volume":"38","author":"NB Vakil","year":"2013","unstructured":"Vakil NB, Huff FJ, Cundy KC: Randomised clinical trial: arbaclofen placarbil in gastro-oesophageal reflux disease\u2013insights into study design for transient lower sphincter relaxation inhibitors. Aliment Pharmacol Ther. 2013, 38 (2): 107-117. 10.1111\/apt.12363.","journal-title":"Aliment Pharmacol Ther"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-14-177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-14-177\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-14-177","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-14-177.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T09:02:12Z","timestamp":1548147732000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-14-177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,10]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["1200"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-14-177","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,10]]},"assertion":[{"value":"1 May 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"177"}}